Showing results (1301-1310 of 1,427) with videos related to

Sort By:
Pageof 143
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
Steatotic Liver Disease Classification is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Katrine Holtz Thorhauge, Peter Andersen, et al.
Nature Communications|February 8, 2018
Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-bindingHou-Fu Guo, Chi-Lin Tsai, Masahiko Terajima, et al.
BMC Ecology|October 17, 2019
A systematic survey of regional multi-taxon biodiversity: evaluating strategies and coverageAne Kirstine Brunbjerg, Hans Henrik Bruun, Lars Brøndum, et al.
Nature Communications|July 11, 2018
Author Correction: Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-bindingHou-Fu Guo, Chi-Lin Tsai, Masahiko Terajima, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 22, 2013
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and designDamian J Kelly, Gerald P McCann, Daniel Blackman, et al.
Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.
JHEP Reports : Innovation in Hepatology|December 19, 2024
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Nikolaj Torp, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|January 6, 2026
P NPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosisSophie Gensluckner, Helle Lindholm Schnefeld, Jan Embacher, et al.
Pageof 143